11 Recruiting Studies Using Oleclumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Oleclumab
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
📍 Research Site — Tucson, Arizona
Triple Negative Breast Neoplasms
View Study & Checklist ➔Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
📍 Research Site — La Jolla, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
📍 Research Site — San Diego, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
📍 Research Site — Iowa City, Iowa
Metastatic Non-Small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
📍 Research Site — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Borderline Resectable Pancreatic Adenocarcinoma
View Study & Checklist ➔Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Angiosarcoma
View Study & Checklist ➔COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
📍 Research Site — Los Angeles, California
Metastatic Microsatellite-stable Colorectal Cancer
View Study & Checklist ➔The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2
📍 Montefiore Medical Center — The Bronx, New York
Non-small Cell Lung Cancer
View Study & Checklist ➔Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
📍 Research Site — Little Rock, Arkansas
Non-small Cell Lung Cancer
View Study & Checklist ➔Durvalumab and Oleclumab in Resectable PDAC
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔